Bi-, tri- or tetranuclear mixed metal complexes containing group ib and iva elements for electronic devices such as oleds
US-2015280150-A1 · Oct 1, 2015 · US
US10121975B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10121975-B2 |
| Application number | US-201414302042-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 11, 2014 |
| Priority date | Jul 3, 2013 |
| Publication date | Nov 6, 2018 |
| Grant date | Nov 6, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A compound comprising a ligand L A selected from: as well as, devices and formulations containing the compound are disclosed. In the compounds, independently X 1 -X 6 are CH or N; Y 1 -Y 12 are independently selected from CH, N, and C-APR 1 ′R 1 ″; when present, exactly one of Y 1 through Y 12 is C-APR 1 ′R 1 ″ in L A8 ; A is selected from a single bond, —CR A R B —, —NR A —, —O—, —S— and —SiR A R B —; and R, R 1 ′, R 1 ″, R 2 , R 3 , R A , and R B are each independently a substituent selected from hydrogen, deuterium, alkyl, cycloalkyl, aryl, and combinations thereof. The P-atom of the ligand L A is bonded to a metal M having an atomic weight of at least 40.
Opening claim text (preview).
We claim: 1. A compound comprising a metal and a ligand L A selected from the group of ligands consisting of: wherein Y 1 , Y 2 , Y 3 , Y 4 , Y 5 , Y 6 , Y 7 , Y 8 , Y 9 , Y 10 , Y 11 , and Y 12 are independently selected from the group consisting of CH, C bonded to metal M, N, and C-APR 1 ′R 1 ″, and the ligand L A is bidentate with a first bond to the metal M formed with the P-atom of the C-APR 1 ′R 1 ″ and a second bond to the metal M formed with a ring carbon of ligand L A5 , ligand L A6 , ligand L A7 , or ligand L A8 ; wherein the metal M has an atomic weight of at least 40; wherein exactly one of Y 1 through Y 8 is C-APR 1 ′R 1 ″ in L A5 and L A6 , and exactly one of Y 1 through Y 8 is the ring carbon bonded to the metal; wherein exactly one of Y 1 through Y 10 is C-APR 1 ′R 1 ″ in L A7 , and exactly one of Y 1 through Y 10 is the ring carbon bonded to the metal; wherein exactly one of Y 1 through Y 12 is C-APR 1 ′R 1 ″ in L A8 , and exactly one of Y 1 through Y 12 is the ring carbon bonded to the metal; wherein A is selected from the group consisting of a single bond, —CR A R B —, —NR A —, —O—, —S— and —SiR A R B —; wherein R, R 1 ′, R 1 ″, R 2 , R 3 , R A , and R B are each independently selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, and aryl. 2. The compound of claim 1 , wherein M is a metal selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu. 3. The compound of claim 1 , wherein R 1 ′ and R 1 ″ are each phenyl. 4. The compound of claim 1 , wherein the compound has the formula M(L A ) m (L B ) n , wherein the ligand L B is a different ligand from the ligand L A ; wherein m is an integer from 1 to the maximum number of ligands that may be coordinated to the metal M; and m+n is the maximum number of ligands that may be coordinated to the metal M, and the ligand L B is selected from the group of ligands consisting of: wherein: X 7 , X 8 , X 9 , and X 10 are independently selected from the group consisting of CH, and N; X 11 , X 12 , and X 13 are independently selected from the group consisting of CH, CR′, and N; R a , R b , and R c , may represent mono, di, tri, or tetra substitution, or no substitution; R d may represent mono, di, or tri substitution, or no substitution; R′, R a , R b , R c , R d are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, carboxylic acids, ester, nitrile, isonitrile, and phosphino; and two adjacent substituents of R a , R b , R c , and R d are optionally joined to form a fused ring; wherein dotted arcs of ligand L B28 and ligand L B29 represent optional fused rings, which can be cyclic, heterocyclic, aromatic, or heteroaromatic, and which can be further substituted; and if present, each end of each dotted arc is fused to a carbon atom. 5. The compound of claim 1 , wherein the compound has the formula M(L A ) x (L B ) y (LC) z , wherein the ligands L A , L B and L C are three different ligands, and L C is a monodentate ligand; x is 1, or 2; y is 0, 1, or 2; z is 0, 1, or 2; and wherein x+y+z is the oxidation state of the metal M. 6. The compound of claim 1 , wherein the compound is homoleptic. 7. The compound of claim 6 , wherein the compound has a facial configuration. 8. The compound of claim 6 , wherein the compound has a meridional configuration. 9. The compound of claim 1 , wherein ligand L A is selected from the group consisting of: 10. The compound of claim 9 , wherein the second bond between the metal and the ligand L A is formed by: a carbon atom of Ring 2 of the ligands L A5-1 and L A6-1 . 11. The compound of claim 1 , wherein the compound has the formula M(L A ) m (L B ) n , wherein the ligand L B is a different ligand from the ligand L A ; wherein m is an integer from 1 to the maximum number of ligands that may be coordinated to the metal M; and m+n is the maximum number of ligands that may be coordinated to the metal M, and the ligand L B is selected from the group of ligands consisting of: wherein: X 7 , X 8 , X 9 , and X 10 are independently selected from the group consisting of CH, and N; X 11 , X 12 , and X 13 are independently selected from the group consisting of CH, CR′, and N; R a , R b , and R c , may represent mono, di, tri, or tetra substitution, or no substitution; R′, R a , R b , and R c are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, carboxylic acids, ester, nitrile, isonitrile, and phosphino; and two adjacent substituents of R a , R b , and R c are optionally joined to form a fused ring; wherein dotted arcs of ligand L B29 represent optional fused rings, which can be cyclic, heterocyclic, aromatic, or heteroaromatic, and which can be further substituted; and if present, each end of each dotted arc is fused to a carbon atom. 12. The compound of claim 11 , where the compound is selected from the group consisting of: wherein is selected from the group consisting of L B1 through L B10 , L B12 through L B25 , and L B29 , wherein each R 1 is independently selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, and aryl, and wherein n=0, 1, or 2. 13. A first device comprising an organic light emitting device, the organic light emitting device comprising: an anode; a cathode; and an organic layer, disposed between the anode and the cathode, comprising a compound comprising a metal and a ligand L A selected from the group of ligands consisting of:
containing oxygen as the only heteroatom · CPC title
of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title
containing two nitrogen atoms as heteroatoms · CPC title
Electricity · mapped topic
Electricity · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.